HEMOBIOTECH, INC. — Form D
HEMOBIOTECH, INC. of DALLAS, TX, a company, filed a Form D exempt-offering notice with the SEC on 2009-11-04. The offering totals $350K, of which $160K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2009-11-04
- Form: D
- Accession: 0001411023-09-000008
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $350K
- Amount sold: $160K
- Remaining: $190K
- Investors: 5
- Date of first sale: 2009-10-14
- Security types: equity, debt
- Revenue range: No Revenues
- SEC file number: 021-68647
Issuer
- Name: HEMOBIOTECH, INC.
- CIK: 0001301348
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 5001 SPRING VALLEY ROAD, DALLAS, TX, 75244
- Phone: 972-455-8950
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Robert P Baron | Director | Dallas, TX |
| Arthur P Bollon | Director | Quakertown, PA |
| Robert P Comer | Director | Dallas, TX |
| Robert P Dragoo | Director | Dallas, TX |
| Bernard P Mittemeyer | Director | Dallas, TX |
| Ghassan P Nino | Director | Dallas, TX |
| Arthur P Bollon | Executive Officer | Quakertown, PA |
| Mario P Feola | Executive Officer | Dallas, TX |
| Mark P Rosenblum | Executive Officer | Dallas, TX |
| Jan P Simoni | Executive Officer | Dallas, TX |
| Robert Baron | Director | King of Prussia, PA |
| Robert Comer | Director | Dallas, TX |
| Robert Comer | Executive Officer | Dallas, TX |
| Bernhard Mittemeyer | Director | Dallas, TX |
| Ghassan Nino | Director | Dallas, TX |
| Robert Dragoo, Jr. | Director | Dallas, TX |
| Arthur Bollon | Director | Dallas, TX |
| Arthur Bollon | Executive Officer | Dallas, TX |
Other filings by this issuer (1)
More